/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
Company

Livongo

Filtered to Regulatory & Policy ×
5 articles stable

Livongo has appeared in 5 articles since 2018-04. Coverage peaked in 2020Q3 with 1 articles. Frequently mentioned alongside IPO.

Articles
5
mentions
Velocity
0.0%
growth rate
Acceleration
0.000
velocity change
Sources
3
publications

Coverage Timeline

2020-08-06
TechCrunch 5 related

Telemedicine provider Teladoc Health signs a $18.5B deal to buy Livongo, maker of connected devices for managing diabetes and other chronic conditions

In a sign of the growing importance and value of digital healthcare in the world of medicine, two of the industry's publicly traded companies …

2020-06-05
CNBC 3 related

Sources: telemedicine company Amwell, formerly American Well, confidentially files for IPO after it raised $194M in May; will seek September offering

Amwell IPO after a $194M private raise and following Livongo, One Medical, and Teladoc raising a combined $1.6 billion in convertible notes in the last month. https://twitter.com/...

2019-07-26
CNBC 1 related

Livongo, which makes a platform to help people manage chronic conditions, raises $350M+ in its IPO, closing up 36% at $38.10 and valued at ~$3.6B

Christina Farr / CNBC :

2019-06-28
CNBC 1 related

Livongo, which sells connected devices to monitor diabetes, files for an IPO, says it had $32.06M in revenue in Q1 2019 with a net loss of $14.96M

KEY POINTS  — The company provide tools for people with chronic disease, and works with some 600 employers and health plans.

2018-04-16
Xconomy 6 related

Livongo, which helps patients manage diabetes and hypertension via connected devices and a cloud based platform, raises $105M Series E at $800M+ valuation

Livongo Health, a startup that develops connected devices and software for patients with diabetes and other chronic conditions …

Loading articles...

Quarterly Coverage

Top Sources

Narrative

Loading narrative...

Relationships

Loading graph...